Pivotal in Serbia
E-mail: bd@pivotalcr.com
Other Pivotal's locations around the world
About Pivotal
Pivotal vision is to be the most customer-centric CRO on earth. We know that biotech and pharma companies look for ways to accelerate clinical trial execution, so we deliver faster, smarter, scientific, and affordable clinical development solutions.
Founded in 2001 by Dr. Ibrahim Farr, Pivotal is a full-service CRO headquartered in Madrid, operating in >25 countries across Europe, the Middle East, and the US, with some 220 employees. We have built focused specialization across all therapeutic areas and performed to date >600 clinical trials, with a strong hub in oncology/hemato-oncology, innovative gene and cell therapies, rare diseases, and early phase clinical trials, that enable us to tackle our customers’ most difficult challenges.
Yet, Pivotal does also perform in other therapeutic areas which encompass from infectious diseases/vaccines to cardio and cerebro-vascular to endocrinology and metabolic syndrome to neurological and psychiatric disorders and many others, and managed clinical research with other “more classical” investigational products including “medical devices” and has been involved in other clinical research projects at “later” phases, including phase 3 and post-authorization phase 4 and non-interventional studies.
As a data-driven CRO, we leverage our near real-time advanced analytics platform to discover insights that anticipate trial risks and predict their impact making us an efficient, agile, and resilient partner for Phase 1, 2, 3 and 4 clinical trials.
Our Innovative Organizational Model connects scientific, medical, and technological expertise to deliver patient-centric and PI-centric trials that reduce timelines, cut costs, and maximize our clients' drug development value chain.
Today, at a distance of 25 years since inception, we are proud of have being involved in the activation, conduction, and execution of nearly 600 different clinical research projects in quite distinct therapeutic areas and phases and with much diverse investigational compounds and products. All in all, today, with an accumulated experience resulting from working with >15,000 sites and >100,000 patients, we bear sufficient knowledge and experience in clinical research to ensure our customers that they are in good hands when partnering up with Pivotal.